TARRYTOWN, N.Y., March 12 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere," Nasdaq: EMIS) announced today an addendum to its fourth quarter and year ended 2006 financial...
TARRYTOWN, N.Y., Jan. 16 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere", Nasdaq: EMIS) today announced that Michael M. Goldberg, M.D. Emisphere's Chief Executive Officer...
Company to Present Results Today During Presentation at Rodman and Renshaw Healthcare Conference TARRYTOWN, N.Y., Nov. 8 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere...
No Further Toxicology Studies are Planned for the NDA Submission of Oral Calcitonin TARRYTOWN, N.Y., May 25 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere", Nasdaq: EMIS...
Novartis Pharma AG elects to develop oral growth hormone using Emisphere's technology TARRYTOWN, N.Y., May 1 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. ("Emisphere", Nasdaq: EMIS...
Emisphere Technologies to Hold Annual Shareholders Meeting on May 23, 2005 TARRYTOWN, N.Y., May 13 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. will host its annual shareholders...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約